mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |